Phase I trial of bromopyruvate (PSL-001) in patients with primary and/or metastatic liver cancer.

Trial Profile

Phase I trial of bromopyruvate (PSL-001) in patients with primary and/or metastatic liver cancer.

Planning
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2013

At a glance

  • Drugs Bromopyruvate (Primary)
  • Indications Liver cancer; Liver metastases
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Jul 2013 New trial record
    • 24 Jul 2013 The US FDA has approved the IND application for phase I clinical evaluation of bromopyruvate and this trial is expected to be initiated in early 2014, according to a PreScience Labs media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top